PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 8, 2026European Stroke Journal0 citationsOpen Access

Abstract Number: Esoc2026a636 Tandem Lesion Strokes: To Stent or Not to Stent, Insights From a Decade of Experience at a Comprehensive Stroke Center in Argentina

View Full Paper
JRJulieta RosalesAAAlejandro Gonzalez AquinesJRJulieta Russo

Key Points

  • This research aims to evaluate the safety and efficacy of endovascular carotid artery stenting (eCAS) compared to mechanical thrombectomy alone (MTa) in patients with tandem lesion strokes (TLS).
  • Retrospective, observational analysis of consecutive patients with anterior circulation TLS presenting within 24 hours from symptom onset.
  • Total of 111 patients treated at a comprehensive stroke center from 2015 to 2025, with 74 receiving eCAS and 37 undergoing MTa.
  • Primary outcomes included 90-day modified Rankin Scale (mRS) shift, rates of successful reperfusion (TICI 2b or higher), and safety outcomes like symptomatic intracerebral hemorrhage (sICH).
  • eCAS was associated with higher reperfusion rates and improved 90-day functional outcomes, as measured by mRS scores.
  • No increased risk of sICH or mortality was observed with eCAS during MT compared to MTa alone.
  • The findings suggest eCAS is a feasible option for selected TLS patients, indicating the need for further prospective randomized clinical trials.

Abstract

Abstract Background and aims Tandem lesion strokes (TLS), defined as simultaneous intracranial large-medium-vessel LVO/MeVO) and cervical internal carotid artery (ICA) stenosis or occlusion, represent 10–20% strokes. They are associated with poorer outcomes, reduced recanalization rates, higher disability and increased mortality. We aim to assess the safety and efficacy of eCAS versus MTa approach in patients presenting with anterior circulation TLS at a single comprehensive stroke center in Argentina. Methods Retrospective, observational, cross-sectional study analyzed consecutive patients with anterior circulation TLS 24 hours of symptoms onset treated between 2015-2025. Primary efficacy outcomes: ordinal shift in 90-day mRS score, mRS 0–1 and mRS 0–2 at 90 days. Secondary efficacy outcome: TICI 2b or higher. Primary safety outcomes: sICH, in hospital mortality and at 90 days. Secondary safety outcomes: early neurological deterioration (increase of 4 NIHSS points within 24 hours) and in hospital ipsilateral recurrent ischemic stroke. Results A total of 111 patients were included (mean age 71.2 ± 12.6 years; 68.5% male), of whom 74 (67%) underwent eCAS and 37 (33%) received MTa. Baseline features were similar in both groups. Efficacy and safety outcomes are presented in Table 1. Shift in mRS scores at 90 is represented Figure 1 Conclusions In this single-center experience, eCAS during MT for TLS was associated with higher reperfusion rates and improved functional outcomes without increased sICH or mortality. These findings support eCAS as a feasible and safe strategy in selected patients and highlight the need for prospective RCT. Conflict of interest Julieta Rosales: nothing to disclose Table 1 - belongs to Results Figure 1 - belongs to Results

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rosales et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e42bfa21ec5bbf06778https://doi.org/10.1093/esj/aakag023.380
Ask AI
Helpful
Bookmark
Share
View Full Paper